Pretargeting (imaging) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pretargeting (imaging)" in English language version.

refsWebsite

Global rank English rank

50nih.gov

4^th place

27worldcat.org

5^th place

25doi.org

2^nd place

10semanticscholar.org

11^th place

8^th place

3harvard.edu

18^th place

17^th place

2nature.com

234^th place

397^th place

1snmjournals.org

low place

1aacrjournals.org

8,869^th place

8,487^th place

1nejm.org

2,374^th place

6,027^th place

1elsevier.com

610^th place

704^th place

1springer.com

274^th place

309^th place

aacrjournals.org

cancerres.aacrjournals.org

Wisser, R.W (September 1956). "A Study of the Preparation, Localization, and Effects of Antitumor Antibodies Labeled with I131". Cancer Research. 16 (8): 761–773. PMID 13364902.

doi.org

Wu, Anna M.; Olafsen, Tove (May 2008). "Antibodies for Molecular Imaging of Cancer". The Cancer Journal. 14 (3): 191–197. doi:10.1097/ppo.0b013e31817b07ae. ISSN 1528-9117. PMID 18536559. S2CID 36963226.
Knowles, Scott M.; Wu, Anna M. (2012-11-01). "Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology". Journal of Clinical Oncology. 30 (31): 3884–3892. doi:10.1200/JCO.2012.42.4887. ISSN 0732-183X. PMC 3478579. PMID 22987087.
Boerman, Otto C.; Oyen, Wim J. G. (2011-08-01). "Immuno-PET of Cancer: A Revival of Antibody Imaging". Journal of Nuclear Medicine. 52 (8): 1171–1172. doi:10.2967/jnumed.111.089771. ISSN 0161-5505. PMID 21764784. S2CID 22588904.
Pressman, David; Korngold, Leonhard (1953). "The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies". Cancer. 6 (3): 619–623. doi:10.1002/1097-0142(195305)6:3<619::aid-cncr2820060319>3.0.co;2-y. ISSN 1097-0142. PMID 13042784. S2CID 29001745.
Goldenberg, David M.; DeLand, Frank; Kim, Euishin; Bennett, Sidney; Primus, F. James; van Nagell, John R.; Estes, Norman; DeSimone, Philip; Rayburn, Pam (1978-06-22). "Use of Radio-Labeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning". New England Journal of Medicine. 298 (25): 1384–1388. doi:10.1056/NEJM197806222982503. ISSN 0028-4793. PMID 349387.
Köhler, G.; Milstein, C. (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. ISSN 1476-4687. PMID 1172191. S2CID 4161444.
Tjandra, J. J.; Ramadi, L.; McKenzie, I. F. (December 1990). "Development of human anti-murine antibody (HAMA) response in patients". Immunology and Cell Biology. 68 ( Pt 6) (6): 367–376. doi:10.1038/icb.1990.50. ISSN 0818-9641. PMID 1711007. S2CID 9138513.
Chames, Patrick; Van Regenmortel, Marc; Weiss, Etienne; Baty, Daniel (May 2009). "Therapeutic antibodies: successes, limitations and hopes for the future". British Journal of Pharmacology. 157 (2): 220–233. doi:10.1111/j.1476-5381.2009.00190.x. ISSN 0007-1188. PMC 2697811. PMID 19459844.
Lee, Chang-Han; Kang, Tae Hyun; Godon, Ophélie; Watanabe, Makiko; Delidakis, George; Gillis, Caitlin M.; Sterlin, Delphine; Hardy, David; Cogné, Michel; Macdonald, Lynn E.; Murphy, Andrew J. (December 2019). "An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence". Nature Communications. 10 (1): 5031. Bibcode:2019NatCo..10.5031L. doi:10.1038/s41467-019-13108-2. ISSN 2041-1723. PMC 6834678. PMID 31695028.
Deri, Melissa A.; Zeglis, Brian M.; Francesconi, Lynn C.; Lewis, Jason S. (January 2013). "PET Imaging with 89Zr: From Radiochemistry to the Clinic". Nuclear Medicine and Biology. 40 (1): 3–14. doi:10.1016/j.nucmedbio.2012.08.004. ISSN 0969-8051. PMC 3517725. PMID 22998840.
Reardan, Dayton T.; Meares, Claude F.; Goodwin, David A.; McTigue, Maureen; David, Gary S.; Stone, Mary R.; Leung, Julia P.; Bartholomew, Richard M.; Frincke, James M. (July 1985). "Antibodies against metal chelates". Nature. 316 (6025): 265–268. Bibcode:1985Natur.316..265R. doi:10.1038/316265a0. ISSN 0028-0836. PMID 3927170. S2CID 4273142.
Goodwin, D. A.; Mears, C. F.; McTigue, M.; David, G. S. (August 1986). "Monoclonal antibody hapten radiopharmaceutical delivery". Nuclear Medicine Communications. 7 (8): 569–580. doi:10.1097/00006231-198608000-00002. ISSN 0143-3636. PMID 3095721. S2CID 31950034.
Sharkey, Robert M.; Rossi, Edmund A.; Chang, Chien-Hsing; Goldenberg, David M. (February 2010). "Improved Cancer Therapy and Molecular Imaging with Multivalent, Multispecific Antibodies". Cancer Biotherapy and Radiopharmaceuticals. 25 (1): 1–12. doi:10.1089/cbr.2009.0690. ISSN 1084-9785. PMC 2883519. PMID 20187791.
Goldenberg, D. M.; Rossi, E. A.; Sharkey, R. M.; McBride, W. J.; Chang, C.-H. (2007-12-12). "Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting". Journal of Nuclear Medicine. 49 (1): 158–163. doi:10.2967/jnumed.107.046185. ISSN 0161-5505. PMID 18077530. S2CID 32847549.
Goldenberg, David M.; Chatal, Jean-Francois; Barbet, Jacques; Boerman, Otto; Sharkey, Robert M. (March 2007). "Cancer imaging and therapy with bispecific antibody pretargeting". Update on Cancer Therapeutics. 2 (1): 19–31. doi:10.1016/j.uct.2007.04.003. PMC 2034280. PMID 18311322.
Sharkey, Robert M.; Karacay, Habibe; Goldenberg, David M. (2010). "Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides". Cancer. 116 (S4): 1134–1145. doi:10.1002/cncr.24802. ISSN 1097-0142. PMC 2820147. PMID 20127947.
Sharkey, Robert M.; Rossi, Edmund A.; McBride, William J.; Chang, Chien-Hsing; Goldenberg, David M. (May 2010). "Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy". Seminars in Nuclear Medicine. 40 (3): 190–203. doi:10.1053/j.semnuclmed.2009.12.002. PMC 2855818. PMID 20350628.
Goldenberg, David M.; Chang, Chien-Hsing; Rossi, Edmund A.; J, William; McBride, null; Sharkey, Robert M. (2012). "Pretargeted molecular imaging and radioimmunotherapy". Theranostics. 2 (5): 523–540. doi:10.7150/thno.3582. ISSN 1838-7640. PMC 3364558. PMID 22737190.
Michael Green, N. (1990), "[5] Avidin and streptavidin", Avidin-Biotin Technology, Methods in Enzymology, vol. 184, Elsevier, pp. 51–67, doi:10.1016/0076-6879(90)84259-j, ISBN 978-0-12-182085-5, PMID 2388586, retrieved 2020-09-30
Liu, Guozheng; Hnatowich, Donald J. (2008-11-19). "A Semiempirical Model of Tumor Pretargeting". Bioconjugate Chemistry. 19 (11): 2095–2104. doi:10.1021/bc8002748. ISSN 1043-1802. PMC 2645947. PMID 18839978.
Sharkey, Robert M.; Chang, Chien-Hsing; Rossi, Edmund A.; McBride, William J.; Goldenberg, David M. (June 2012). "Pretargeting: taking an alternate route for localizing radionuclides". Tumor Biology. 33 (3): 591–600. doi:10.1007/s13277-012-0367-6. ISSN 1010-4283. PMID 22396041. S2CID 16162151.
Sharkey, Robert M.; Goldenberg, David M. (2006-01-01). "Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting". Cancer Investigation. 24 (1): 82–97. doi:10.1080/07357900500449553. ISSN 0735-7907. PMID 16466997. S2CID 38314674.
Goldenberg, David M.; Sharkey, Robert M.; Paganelli, Giovanni; Barbet, Jacques; Chatal, Jean-François (2006-02-10). "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy". Journal of Clinical Oncology. 24 (5): 823–834. doi:10.1200/jco.2005.03.8471. ISSN 0732-183X. PMID 16380412.

dx.doi.org

Wu, Anna M.; Olafsen, Tove (May 2008). "Antibodies for Molecular Imaging of Cancer". The Cancer Journal. 14 (3): 191–197. doi:10.1097/ppo.0b013e31817b07ae. ISSN 1528-9117. PMID 18536559. S2CID 36963226.
Goldenberg, David M.; Sharkey, Robert M.; Paganelli, Giovanni; Barbet, Jacques; Chatal, Jean-François (2006-02-10). "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy". Journal of Clinical Oncology. 24 (5): 823–834. doi:10.1200/jco.2005.03.8471. ISSN 0732-183X. PMID 16380412.

elsevier.com

linkinghub.elsevier.com

Michael Green, N. (1990), "[5] Avidin and streptavidin", Avidin-Biotin Technology, Methods in Enzymology, vol. 184, Elsevier, pp. 51–67, doi:10.1016/0076-6879(90)84259-j, ISBN 978-0-12-182085-5, PMID 2388586, retrieved 2020-09-30

harvard.edu

ui.adsabs.harvard.edu

Köhler, G.; Milstein, C. (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. ISSN 1476-4687. PMID 1172191. S2CID 4161444.
Lee, Chang-Han; Kang, Tae Hyun; Godon, Ophélie; Watanabe, Makiko; Delidakis, George; Gillis, Caitlin M.; Sterlin, Delphine; Hardy, David; Cogné, Michel; Macdonald, Lynn E.; Murphy, Andrew J. (December 2019). "An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence". Nature Communications. 10 (1): 5031. Bibcode:2019NatCo..10.5031L. doi:10.1038/s41467-019-13108-2. ISSN 2041-1723. PMC 6834678. PMID 31695028.
Reardan, Dayton T.; Meares, Claude F.; Goodwin, David A.; McTigue, Maureen; David, Gary S.; Stone, Mary R.; Leung, Julia P.; Bartholomew, Richard M.; Frincke, James M. (July 1985). "Antibodies against metal chelates". Nature. 316 (6025): 265–268. Bibcode:1985Natur.316..265R. doi:10.1038/316265a0. ISSN 0028-0836. PMID 3927170. S2CID 4273142.

nature.com

Köhler, G.; Milstein, C. (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. ISSN 1476-4687. PMID 1172191. S2CID 4161444.
Reardan, Dayton T.; Meares, Claude F.; Goodwin, David A.; McTigue, Maureen; David, Gary S.; Stone, Mary R.; Leung, Julia P.; Bartholomew, Richard M.; Frincke, James M. (July 1985). "Antibodies against metal chelates". Nature. 316 (6025): 265–268. Bibcode:1985Natur.316..265R. doi:10.1038/316265a0. ISSN 0028-0836. PMID 3927170. S2CID 4273142.

nejm.org

Goldenberg, David M.; DeLand, Frank; Kim, Euishin; Bennett, Sidney; Primus, F. James; van Nagell, John R.; Estes, Norman; DeSimone, Philip; Rayburn, Pam (1978-06-22). "Use of Radio-Labeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning". New England Journal of Medicine. 298 (25): 1384–1388. doi:10.1056/NEJM197806222982503. ISSN 0028-4793. PMID 349387.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wu, Anna M.; Olafsen, Tove (May 2008). "Antibodies for Molecular Imaging of Cancer". The Cancer Journal. 14 (3): 191–197. doi:10.1097/ppo.0b013e31817b07ae. ISSN 1528-9117. PMID 18536559. S2CID 36963226.
Knowles, Scott M.; Wu, Anna M. (2012-11-01). "Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology". Journal of Clinical Oncology. 30 (31): 3884–3892. doi:10.1200/JCO.2012.42.4887. ISSN 0732-183X. PMC 3478579. PMID 22987087.
Boerman, Otto C.; Oyen, Wim J. G. (2011-08-01). "Immuno-PET of Cancer: A Revival of Antibody Imaging". Journal of Nuclear Medicine. 52 (8): 1171–1172. doi:10.2967/jnumed.111.089771. ISSN 0161-5505. PMID 21764784. S2CID 22588904.
Pressman, David; Korngold, Leonhard (1953). "The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies". Cancer. 6 (3): 619–623. doi:10.1002/1097-0142(195305)6:3<619::aid-cncr2820060319>3.0.co;2-y. ISSN 1097-0142. PMID 13042784. S2CID 29001745.
Wisser, R.W (September 1956). "A Study of the Preparation, Localization, and Effects of Antitumor Antibodies Labeled with I131". Cancer Research. 16 (8): 761–773. PMID 13364902.
Goldenberg, David M.; DeLand, Frank; Kim, Euishin; Bennett, Sidney; Primus, F. James; van Nagell, John R.; Estes, Norman; DeSimone, Philip; Rayburn, Pam (1978-06-22). "Use of Radio-Labeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning". New England Journal of Medicine. 298 (25): 1384–1388. doi:10.1056/NEJM197806222982503. ISSN 0028-4793. PMID 349387.
Köhler, G.; Milstein, C. (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. ISSN 1476-4687. PMID 1172191. S2CID 4161444.
Tjandra, J. J.; Ramadi, L.; McKenzie, I. F. (December 1990). "Development of human anti-murine antibody (HAMA) response in patients". Immunology and Cell Biology. 68 ( Pt 6) (6): 367–376. doi:10.1038/icb.1990.50. ISSN 0818-9641. PMID 1711007. S2CID 9138513.
Chames, Patrick; Van Regenmortel, Marc; Weiss, Etienne; Baty, Daniel (May 2009). "Therapeutic antibodies: successes, limitations and hopes for the future". British Journal of Pharmacology. 157 (2): 220–233. doi:10.1111/j.1476-5381.2009.00190.x. ISSN 0007-1188. PMC 2697811. PMID 19459844.
Lee, Chang-Han; Kang, Tae Hyun; Godon, Ophélie; Watanabe, Makiko; Delidakis, George; Gillis, Caitlin M.; Sterlin, Delphine; Hardy, David; Cogné, Michel; Macdonald, Lynn E.; Murphy, Andrew J. (December 2019). "An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence". Nature Communications. 10 (1): 5031. Bibcode:2019NatCo..10.5031L. doi:10.1038/s41467-019-13108-2. ISSN 2041-1723. PMC 6834678. PMID 31695028.
Rosebrough, S. F.; Grossman, Z. D.; McAfee, J. G.; Kudryk, B. J.; Subramanian, G.; Ritter-Hrncirik, C. A.; Witanowski, L. S.; Tillapaugh-Fay, G.; Urrutia, E.; Zapf-Longo, C. (July 1988). "Thrombus imaging with indium-111 and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab')2 and Fab fragments". Journal of Nuclear Medicine. 29 (7): 1212–1222. ISSN 0161-5505. PMID 3392581.
Murray, J. L.; Rosenblum, M. G.; Lamki, L.; Glenn, H. J.; Krizan, Z.; Hersh, E. M.; Plager, C. E.; Bartholomew, R. M.; Unger, M. W.; Carlo, D. J. (January 1987). "Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018". Journal of Nuclear Medicine. 28 (1): 25–33. ISSN 0161-5505. PMID 3794809.
Deri, Melissa A.; Zeglis, Brian M.; Francesconi, Lynn C.; Lewis, Jason S. (January 2013). "PET Imaging with 89Zr: From Radiochemistry to the Clinic". Nuclear Medicine and Biology. 40 (1): 3–14. doi:10.1016/j.nucmedbio.2012.08.004. ISSN 0969-8051. PMC 3517725. PMID 22998840.
Knight, James C; Cornelissen, Bart (2014-03-20). "Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy". American Journal of Nuclear Medicine and Molecular Imaging. 4 (2): 96–113. ISSN 2160-8407. PMC 3992206. PMID 24753979.
Reardan, Dayton T.; Meares, Claude F.; Goodwin, David A.; McTigue, Maureen; David, Gary S.; Stone, Mary R.; Leung, Julia P.; Bartholomew, Richard M.; Frincke, James M. (July 1985). "Antibodies against metal chelates". Nature. 316 (6025): 265–268. Bibcode:1985Natur.316..265R. doi:10.1038/316265a0. ISSN 0028-0836. PMID 3927170. S2CID 4273142.
Goodwin, D. A.; Mears, C. F.; McTigue, M.; David, G. S. (August 1986). "Monoclonal antibody hapten radiopharmaceutical delivery". Nuclear Medicine Communications. 7 (8): 569–580. doi:10.1097/00006231-198608000-00002. ISSN 0143-3636. PMID 3095721. S2CID 31950034.
Goodwin, D. A.; Meares, C. F.; McCall, M. J.; McTigue, M.; Chaovapong, W. (February 1988). "Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens". Journal of Nuclear Medicine. 29 (2): 226–234. ISSN 0161-5505. PMID 3346734.
Sharkey, Robert M.; Rossi, Edmund A.; Chang, Chien-Hsing; Goldenberg, David M. (February 2010). "Improved Cancer Therapy and Molecular Imaging with Multivalent, Multispecific Antibodies". Cancer Biotherapy and Radiopharmaceuticals. 25 (1): 1–12. doi:10.1089/cbr.2009.0690. ISSN 1084-9785. PMC 2883519. PMID 20187791.
Goldenberg, D. M.; Rossi, E. A.; Sharkey, R. M.; McBride, W. J.; Chang, C.-H. (2007-12-12). "Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting". Journal of Nuclear Medicine. 49 (1): 158–163. doi:10.2967/jnumed.107.046185. ISSN 0161-5505. PMID 18077530. S2CID 32847549.
Goldenberg, David M.; Chatal, Jean-Francois; Barbet, Jacques; Boerman, Otto; Sharkey, Robert M. (March 2007). "Cancer imaging and therapy with bispecific antibody pretargeting". Update on Cancer Therapeutics. 2 (1): 19–31. doi:10.1016/j.uct.2007.04.003. PMC 2034280. PMID 18311322.
Sharkey, Robert M.; Karacay, Habibe; Goldenberg, David M. (2010). "Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides". Cancer. 116 (S4): 1134–1145. doi:10.1002/cncr.24802. ISSN 1097-0142. PMC 2820147. PMID 20127947.
Sharkey, Robert M.; Rossi, Edmund A.; McBride, William J.; Chang, Chien-Hsing; Goldenberg, David M. (May 2010). "Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy". Seminars in Nuclear Medicine. 40 (3): 190–203. doi:10.1053/j.semnuclmed.2009.12.002. PMC 2855818. PMID 20350628.
Goldenberg, David M.; Chang, Chien-Hsing; Rossi, Edmund A.; J, William; McBride, null; Sharkey, Robert M. (2012). "Pretargeted molecular imaging and radioimmunotherapy". Theranostics. 2 (5): 523–540. doi:10.7150/thno.3582. ISSN 1838-7640. PMC 3364558. PMID 22737190.
Le Doussal, J. M.; Martin, M.; Gautherot, E.; Delaage, M.; Barbet, J. (August 1989). "In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate". Journal of Nuclear Medicine. 30 (8): 1358–1366. ISSN 0161-5505. PMID 2787847.
Hnatowich, D. J.; Virzi, F.; Rusckowski, M. (August 1987). "Investigations of avidin and biotin for imaging applications". Journal of Nuclear Medicine. 28 (8): 1294–1302. ISSN 0161-5505. PMID 3612292.
Michael Green, N. (1990), "[5] Avidin and streptavidin", Avidin-Biotin Technology, Methods in Enzymology, vol. 184, Elsevier, pp. 51–67, doi:10.1016/0076-6879(90)84259-j, ISBN 978-0-12-182085-5, PMID 2388586, retrieved 2020-09-30
Boerman, Otto C.; van Schaijk, Frank G.; Oyen, Wim J. G.; Corstens, Frans H. M. (March 2003). "Pretargeted radioimmunotherapy of cancer: progress step by step". Journal of Nuclear Medicine. 44 (3): 400–411. ISSN 0161-5505. PMID 12621007.
Liu, Guozheng; Hnatowich, Donald J. (2008-11-19). "A Semiempirical Model of Tumor Pretargeting". Bioconjugate Chemistry. 19 (11): 2095–2104. doi:10.1021/bc8002748. ISSN 1043-1802. PMC 2645947. PMID 18839978.
Sharkey, Robert M.; Chang, Chien-Hsing; Rossi, Edmund A.; McBride, William J.; Goldenberg, David M. (June 2012). "Pretargeting: taking an alternate route for localizing radionuclides". Tumor Biology. 33 (3): 591–600. doi:10.1007/s13277-012-0367-6. ISSN 1010-4283. PMID 22396041. S2CID 16162151.
Sharkey, Robert M.; Goldenberg, David M. (2006-01-01). "Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting". Cancer Investigation. 24 (1): 82–97. doi:10.1080/07357900500449553. ISSN 0735-7907. PMID 16466997. S2CID 38314674.
Goldenberg, David M.; Sharkey, Robert M.; Paganelli, Giovanni; Barbet, Jacques; Chatal, Jean-François (2006-02-10). "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy". Journal of Clinical Oncology. 24 (5): 823–834. doi:10.1200/jco.2005.03.8471. ISSN 0732-183X. PMID 16380412.

ncbi.nlm.nih.gov

Knowles, Scott M.; Wu, Anna M. (2012-11-01). "Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology". Journal of Clinical Oncology. 30 (31): 3884–3892. doi:10.1200/JCO.2012.42.4887. ISSN 0732-183X. PMC 3478579. PMID 22987087.
Tjandra, J. J.; Ramadi, L.; McKenzie, I. F. (December 1990). "Development of human anti-murine antibody (HAMA) response in patients". Immunology and Cell Biology. 68 ( Pt 6) (6): 367–376. doi:10.1038/icb.1990.50. ISSN 0818-9641. PMID 1711007. S2CID 9138513.
Chames, Patrick; Van Regenmortel, Marc; Weiss, Etienne; Baty, Daniel (May 2009). "Therapeutic antibodies: successes, limitations and hopes for the future". British Journal of Pharmacology. 157 (2): 220–233. doi:10.1111/j.1476-5381.2009.00190.x. ISSN 0007-1188. PMC 2697811. PMID 19459844.
Lee, Chang-Han; Kang, Tae Hyun; Godon, Ophélie; Watanabe, Makiko; Delidakis, George; Gillis, Caitlin M.; Sterlin, Delphine; Hardy, David; Cogné, Michel; Macdonald, Lynn E.; Murphy, Andrew J. (December 2019). "An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence". Nature Communications. 10 (1): 5031. Bibcode:2019NatCo..10.5031L. doi:10.1038/s41467-019-13108-2. ISSN 2041-1723. PMC 6834678. PMID 31695028.
Rosebrough, S. F.; Grossman, Z. D.; McAfee, J. G.; Kudryk, B. J.; Subramanian, G.; Ritter-Hrncirik, C. A.; Witanowski, L. S.; Tillapaugh-Fay, G.; Urrutia, E.; Zapf-Longo, C. (July 1988). "Thrombus imaging with indium-111 and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab')2 and Fab fragments". Journal of Nuclear Medicine. 29 (7): 1212–1222. ISSN 0161-5505. PMID 3392581.
Murray, J. L.; Rosenblum, M. G.; Lamki, L.; Glenn, H. J.; Krizan, Z.; Hersh, E. M.; Plager, C. E.; Bartholomew, R. M.; Unger, M. W.; Carlo, D. J. (January 1987). "Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018". Journal of Nuclear Medicine. 28 (1): 25–33. ISSN 0161-5505. PMID 3794809.
Deri, Melissa A.; Zeglis, Brian M.; Francesconi, Lynn C.; Lewis, Jason S. (January 2013). "PET Imaging with 89Zr: From Radiochemistry to the Clinic". Nuclear Medicine and Biology. 40 (1): 3–14. doi:10.1016/j.nucmedbio.2012.08.004. ISSN 0969-8051. PMC 3517725. PMID 22998840.
Knight, James C; Cornelissen, Bart (2014-03-20). "Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy". American Journal of Nuclear Medicine and Molecular Imaging. 4 (2): 96–113. ISSN 2160-8407. PMC 3992206. PMID 24753979.
Goodwin, D. A.; Mears, C. F.; McTigue, M.; David, G. S. (August 1986). "Monoclonal antibody hapten radiopharmaceutical delivery". Nuclear Medicine Communications. 7 (8): 569–580. doi:10.1097/00006231-198608000-00002. ISSN 0143-3636. PMID 3095721. S2CID 31950034.
Goodwin, D. A.; Meares, C. F.; McCall, M. J.; McTigue, M.; Chaovapong, W. (February 1988). "Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens". Journal of Nuclear Medicine. 29 (2): 226–234. ISSN 0161-5505. PMID 3346734.
Sharkey, Robert M.; Rossi, Edmund A.; Chang, Chien-Hsing; Goldenberg, David M. (February 2010). "Improved Cancer Therapy and Molecular Imaging with Multivalent, Multispecific Antibodies". Cancer Biotherapy and Radiopharmaceuticals. 25 (1): 1–12. doi:10.1089/cbr.2009.0690. ISSN 1084-9785. PMC 2883519. PMID 20187791.
Goldenberg, David M.; Chatal, Jean-Francois; Barbet, Jacques; Boerman, Otto; Sharkey, Robert M. (March 2007). "Cancer imaging and therapy with bispecific antibody pretargeting". Update on Cancer Therapeutics. 2 (1): 19–31. doi:10.1016/j.uct.2007.04.003. PMC 2034280. PMID 18311322.
Sharkey, Robert M.; Karacay, Habibe; Goldenberg, David M. (2010). "Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides". Cancer. 116 (S4): 1134–1145. doi:10.1002/cncr.24802. ISSN 1097-0142. PMC 2820147. PMID 20127947.
Sharkey, Robert M.; Rossi, Edmund A.; McBride, William J.; Chang, Chien-Hsing; Goldenberg, David M. (May 2010). "Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy". Seminars in Nuclear Medicine. 40 (3): 190–203. doi:10.1053/j.semnuclmed.2009.12.002. PMC 2855818. PMID 20350628.
Goldenberg, David M.; Chang, Chien-Hsing; Rossi, Edmund A.; J, William; McBride, null; Sharkey, Robert M. (2012). "Pretargeted molecular imaging and radioimmunotherapy". Theranostics. 2 (5): 523–540. doi:10.7150/thno.3582. ISSN 1838-7640. PMC 3364558. PMID 22737190.
Le Doussal, J. M.; Martin, M.; Gautherot, E.; Delaage, M.; Barbet, J. (August 1989). "In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate". Journal of Nuclear Medicine. 30 (8): 1358–1366. ISSN 0161-5505. PMID 2787847.
Hnatowich, D. J.; Virzi, F.; Rusckowski, M. (August 1987). "Investigations of avidin and biotin for imaging applications". Journal of Nuclear Medicine. 28 (8): 1294–1302. ISSN 0161-5505. PMID 3612292.
Boerman, Otto C.; van Schaijk, Frank G.; Oyen, Wim J. G.; Corstens, Frans H. M. (March 2003). "Pretargeted radioimmunotherapy of cancer: progress step by step". Journal of Nuclear Medicine. 44 (3): 400–411. ISSN 0161-5505. PMID 12621007.
Liu, Guozheng; Hnatowich, Donald J. (2008-11-19). "A Semiempirical Model of Tumor Pretargeting". Bioconjugate Chemistry. 19 (11): 2095–2104. doi:10.1021/bc8002748. ISSN 1043-1802. PMC 2645947. PMID 18839978.

semanticscholar.org

api.semanticscholar.org

Wu, Anna M.; Olafsen, Tove (May 2008). "Antibodies for Molecular Imaging of Cancer". The Cancer Journal. 14 (3): 191–197. doi:10.1097/ppo.0b013e31817b07ae. ISSN 1528-9117. PMID 18536559. S2CID 36963226.
Boerman, Otto C.; Oyen, Wim J. G. (2011-08-01). "Immuno-PET of Cancer: A Revival of Antibody Imaging". Journal of Nuclear Medicine. 52 (8): 1171–1172. doi:10.2967/jnumed.111.089771. ISSN 0161-5505. PMID 21764784. S2CID 22588904.
Pressman, David; Korngold, Leonhard (1953). "The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies". Cancer. 6 (3): 619–623. doi:10.1002/1097-0142(195305)6:3<619::aid-cncr2820060319>3.0.co;2-y. ISSN 1097-0142. PMID 13042784. S2CID 29001745.
Köhler, G.; Milstein, C. (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. ISSN 1476-4687. PMID 1172191. S2CID 4161444.
Tjandra, J. J.; Ramadi, L.; McKenzie, I. F. (December 1990). "Development of human anti-murine antibody (HAMA) response in patients". Immunology and Cell Biology. 68 ( Pt 6) (6): 367–376. doi:10.1038/icb.1990.50. ISSN 0818-9641. PMID 1711007. S2CID 9138513.
Reardan, Dayton T.; Meares, Claude F.; Goodwin, David A.; McTigue, Maureen; David, Gary S.; Stone, Mary R.; Leung, Julia P.; Bartholomew, Richard M.; Frincke, James M. (July 1985). "Antibodies against metal chelates". Nature. 316 (6025): 265–268. Bibcode:1985Natur.316..265R. doi:10.1038/316265a0. ISSN 0028-0836. PMID 3927170. S2CID 4273142.
Goodwin, D. A.; Mears, C. F.; McTigue, M.; David, G. S. (August 1986). "Monoclonal antibody hapten radiopharmaceutical delivery". Nuclear Medicine Communications. 7 (8): 569–580. doi:10.1097/00006231-198608000-00002. ISSN 0143-3636. PMID 3095721. S2CID 31950034.
Goldenberg, D. M.; Rossi, E. A.; Sharkey, R. M.; McBride, W. J.; Chang, C.-H. (2007-12-12). "Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting". Journal of Nuclear Medicine. 49 (1): 158–163. doi:10.2967/jnumed.107.046185. ISSN 0161-5505. PMID 18077530. S2CID 32847549.
Sharkey, Robert M.; Chang, Chien-Hsing; Rossi, Edmund A.; McBride, William J.; Goldenberg, David M. (June 2012). "Pretargeting: taking an alternate route for localizing radionuclides". Tumor Biology. 33 (3): 591–600. doi:10.1007/s13277-012-0367-6. ISSN 1010-4283. PMID 22396041. S2CID 16162151.
Sharkey, Robert M.; Goldenberg, David M. (2006-01-01). "Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting". Cancer Investigation. 24 (1): 82–97. doi:10.1080/07357900500449553. ISSN 0735-7907. PMID 16466997. S2CID 38314674.

snmjournals.org

jnm.snmjournals.org

Boerman, Otto C.; Oyen, Wim J. G. (2011-08-01). "Immuno-PET of Cancer: A Revival of Antibody Imaging". Journal of Nuclear Medicine. 52 (8): 1171–1172. doi:10.2967/jnumed.111.089771. ISSN 0161-5505. PMID 21764784. S2CID 22588904.

springer.com

link.springer.com

Sharkey, Robert M.; Chang, Chien-Hsing; Rossi, Edmund A.; McBride, William J.; Goldenberg, David M. (June 2012). "Pretargeting: taking an alternate route for localizing radionuclides". Tumor Biology. 33 (3): 591–600. doi:10.1007/s13277-012-0367-6. ISSN 1010-4283. PMID 22396041. S2CID 16162151.

worldcat.org

search.worldcat.org

Wu, Anna M.; Olafsen, Tove (May 2008). "Antibodies for Molecular Imaging of Cancer". The Cancer Journal. 14 (3): 191–197. doi:10.1097/ppo.0b013e31817b07ae. ISSN 1528-9117. PMID 18536559. S2CID 36963226.
Knowles, Scott M.; Wu, Anna M. (2012-11-01). "Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology". Journal of Clinical Oncology. 30 (31): 3884–3892. doi:10.1200/JCO.2012.42.4887. ISSN 0732-183X. PMC 3478579. PMID 22987087.
Boerman, Otto C.; Oyen, Wim J. G. (2011-08-01). "Immuno-PET of Cancer: A Revival of Antibody Imaging". Journal of Nuclear Medicine. 52 (8): 1171–1172. doi:10.2967/jnumed.111.089771. ISSN 0161-5505. PMID 21764784. S2CID 22588904.
Pressman, David; Korngold, Leonhard (1953). "The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies". Cancer. 6 (3): 619–623. doi:10.1002/1097-0142(195305)6:3<619::aid-cncr2820060319>3.0.co;2-y. ISSN 1097-0142. PMID 13042784. S2CID 29001745.
Goldenberg, David M.; DeLand, Frank; Kim, Euishin; Bennett, Sidney; Primus, F. James; van Nagell, John R.; Estes, Norman; DeSimone, Philip; Rayburn, Pam (1978-06-22). "Use of Radio-Labeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning". New England Journal of Medicine. 298 (25): 1384–1388. doi:10.1056/NEJM197806222982503. ISSN 0028-4793. PMID 349387.
Köhler, G.; Milstein, C. (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. ISSN 1476-4687. PMID 1172191. S2CID 4161444.
Tjandra, J. J.; Ramadi, L.; McKenzie, I. F. (December 1990). "Development of human anti-murine antibody (HAMA) response in patients". Immunology and Cell Biology. 68 ( Pt 6) (6): 367–376. doi:10.1038/icb.1990.50. ISSN 0818-9641. PMID 1711007. S2CID 9138513.
Chames, Patrick; Van Regenmortel, Marc; Weiss, Etienne; Baty, Daniel (May 2009). "Therapeutic antibodies: successes, limitations and hopes for the future". British Journal of Pharmacology. 157 (2): 220–233. doi:10.1111/j.1476-5381.2009.00190.x. ISSN 0007-1188. PMC 2697811. PMID 19459844.
Lee, Chang-Han; Kang, Tae Hyun; Godon, Ophélie; Watanabe, Makiko; Delidakis, George; Gillis, Caitlin M.; Sterlin, Delphine; Hardy, David; Cogné, Michel; Macdonald, Lynn E.; Murphy, Andrew J. (December 2019). "An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence". Nature Communications. 10 (1): 5031. Bibcode:2019NatCo..10.5031L. doi:10.1038/s41467-019-13108-2. ISSN 2041-1723. PMC 6834678. PMID 31695028.
Rosebrough, S. F.; Grossman, Z. D.; McAfee, J. G.; Kudryk, B. J.; Subramanian, G.; Ritter-Hrncirik, C. A.; Witanowski, L. S.; Tillapaugh-Fay, G.; Urrutia, E.; Zapf-Longo, C. (July 1988). "Thrombus imaging with indium-111 and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab')2 and Fab fragments". Journal of Nuclear Medicine. 29 (7): 1212–1222. ISSN 0161-5505. PMID 3392581.
Murray, J. L.; Rosenblum, M. G.; Lamki, L.; Glenn, H. J.; Krizan, Z.; Hersh, E. M.; Plager, C. E.; Bartholomew, R. M.; Unger, M. W.; Carlo, D. J. (January 1987). "Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018". Journal of Nuclear Medicine. 28 (1): 25–33. ISSN 0161-5505. PMID 3794809.
Deri, Melissa A.; Zeglis, Brian M.; Francesconi, Lynn C.; Lewis, Jason S. (January 2013). "PET Imaging with 89Zr: From Radiochemistry to the Clinic". Nuclear Medicine and Biology. 40 (1): 3–14. doi:10.1016/j.nucmedbio.2012.08.004. ISSN 0969-8051. PMC 3517725. PMID 22998840.
Knight, James C; Cornelissen, Bart (2014-03-20). "Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy". American Journal of Nuclear Medicine and Molecular Imaging. 4 (2): 96–113. ISSN 2160-8407. PMC 3992206. PMID 24753979.
Reardan, Dayton T.; Meares, Claude F.; Goodwin, David A.; McTigue, Maureen; David, Gary S.; Stone, Mary R.; Leung, Julia P.; Bartholomew, Richard M.; Frincke, James M. (July 1985). "Antibodies against metal chelates". Nature. 316 (6025): 265–268. Bibcode:1985Natur.316..265R. doi:10.1038/316265a0. ISSN 0028-0836. PMID 3927170. S2CID 4273142.
Goodwin, D. A.; Mears, C. F.; McTigue, M.; David, G. S. (August 1986). "Monoclonal antibody hapten radiopharmaceutical delivery". Nuclear Medicine Communications. 7 (8): 569–580. doi:10.1097/00006231-198608000-00002. ISSN 0143-3636. PMID 3095721. S2CID 31950034.
Goodwin, D. A.; Meares, C. F.; McCall, M. J.; McTigue, M.; Chaovapong, W. (February 1988). "Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens". Journal of Nuclear Medicine. 29 (2): 226–234. ISSN 0161-5505. PMID 3346734.
Sharkey, Robert M.; Rossi, Edmund A.; Chang, Chien-Hsing; Goldenberg, David M. (February 2010). "Improved Cancer Therapy and Molecular Imaging with Multivalent, Multispecific Antibodies". Cancer Biotherapy and Radiopharmaceuticals. 25 (1): 1–12. doi:10.1089/cbr.2009.0690. ISSN 1084-9785. PMC 2883519. PMID 20187791.
Goldenberg, D. M.; Rossi, E. A.; Sharkey, R. M.; McBride, W. J.; Chang, C.-H. (2007-12-12). "Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting". Journal of Nuclear Medicine. 49 (1): 158–163. doi:10.2967/jnumed.107.046185. ISSN 0161-5505. PMID 18077530. S2CID 32847549.
Sharkey, Robert M.; Karacay, Habibe; Goldenberg, David M. (2010). "Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides". Cancer. 116 (S4): 1134–1145. doi:10.1002/cncr.24802. ISSN 1097-0142. PMC 2820147. PMID 20127947.
Goldenberg, David M.; Chang, Chien-Hsing; Rossi, Edmund A.; J, William; McBride, null; Sharkey, Robert M. (2012). "Pretargeted molecular imaging and radioimmunotherapy". Theranostics. 2 (5): 523–540. doi:10.7150/thno.3582. ISSN 1838-7640. PMC 3364558. PMID 22737190.
Le Doussal, J. M.; Martin, M.; Gautherot, E.; Delaage, M.; Barbet, J. (August 1989). "In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate". Journal of Nuclear Medicine. 30 (8): 1358–1366. ISSN 0161-5505. PMID 2787847.
Hnatowich, D. J.; Virzi, F.; Rusckowski, M. (August 1987). "Investigations of avidin and biotin for imaging applications". Journal of Nuclear Medicine. 28 (8): 1294–1302. ISSN 0161-5505. PMID 3612292.
Boerman, Otto C.; van Schaijk, Frank G.; Oyen, Wim J. G.; Corstens, Frans H. M. (March 2003). "Pretargeted radioimmunotherapy of cancer: progress step by step". Journal of Nuclear Medicine. 44 (3): 400–411. ISSN 0161-5505. PMID 12621007.
Liu, Guozheng; Hnatowich, Donald J. (2008-11-19). "A Semiempirical Model of Tumor Pretargeting". Bioconjugate Chemistry. 19 (11): 2095–2104. doi:10.1021/bc8002748. ISSN 1043-1802. PMC 2645947. PMID 18839978.
Sharkey, Robert M.; Chang, Chien-Hsing; Rossi, Edmund A.; McBride, William J.; Goldenberg, David M. (June 2012). "Pretargeting: taking an alternate route for localizing radionuclides". Tumor Biology. 33 (3): 591–600. doi:10.1007/s13277-012-0367-6. ISSN 1010-4283. PMID 22396041. S2CID 16162151.
Sharkey, Robert M.; Goldenberg, David M. (2006-01-01). "Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting". Cancer Investigation. 24 (1): 82–97. doi:10.1080/07357900500449553. ISSN 0735-7907. PMID 16466997. S2CID 38314674.
Goldenberg, David M.; Sharkey, Robert M.; Paganelli, Giovanni; Barbet, Jacques; Chatal, Jean-François (2006-02-10). "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy". Journal of Clinical Oncology. 24 (5): 823–834. doi:10.1200/jco.2005.03.8471. ISSN 0732-183X. PMID 16380412.